Health Canada drug identification number

DIN 02380242 — ZELBORAF 240 MG

ZELBORAF is a tablet of Vemurafenib marketed by HOFFMANN-LA ROCHE LIMITED. The full Vemurafenib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02380242
Brand name
ZELBORAF
Active ingredient
Vemurafenib
Strength
240 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
HOFFMANN-LA ROCHE LIMITED
Health Canada status
MARKETED
Drug class
BRAF kinase inhibitor (protein kinase inhibitor antineoplastic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.